These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3144161)

  • 1. Advances in the treatment of supraventricular tachycardia.
    Naccarelli GV; Wellens HJ
    Am J Cardiol; 1988 Dec; 62(19):1L-3L. PubMed ID: 3144161
    [No Abstract]   [Full Text] [Related]  

  • 2. A symposium: The use of encainide in supraventricular tachycardias. June 3 and 4, 1988, Bermuda. Proceedings.
    Am J Cardiol; 1988 Dec; 62(19):1L-84L. PubMed ID: 3144162
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term follow-up of incessant supraventricular tachycardia treated with oral encainide.
    Brugada P; Wellens HJ
    Eur Heart J; 1987 Apr; 8(4):369-71. PubMed ID: 3111853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encainide for resistant supraventricular tachycardia in children: follow-up report.
    Strasburger JF; Smith RT; Moak JP; Gothing C; Garson A
    Am J Cardiol; 1988 Dec; 62(19):50L-54L. PubMed ID: 3144168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adrenergic stimulation by isoproterenol in reversal of effects of encainide in supraventricular tachycardia.
    Akhtar M; Niazi I; Naccarelli GV; Tchou P; Rinkenberger R; Dougherty AH; Jazayeri M
    Am J Cardiol; 1988 Dec; 62(19):45L-49L. PubMed ID: 3144167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of encainide and quinidine for supraventricular tachyarrhythmias.
    Mäkynen PJ; Koskinen PJ; Saaristo TE; Liisanantti RK
    Am J Cardiol; 1988 Dec; 62(19):55L-59L. PubMed ID: 3144169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
    Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ectopic atrial arrhythmias and premature atrial complexes in adults with encainide.
    Pool PE; Quart BD
    Am J Cardiol; 1988 Dec; 62(19):60L-62L. PubMed ID: 2462340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
    Kuck KH; Kunze KP; Schlüter M; Duckeck W
    Am J Cardiol; 1988 Dec; 62(19):37L-44L. PubMed ID: 3144166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndrome.
    Miles WM; Zipes DP; Rinkenberger RL; Markel ML; Prystowsky EN; Dougherty AH; Heger JJ; Naccarelli GV
    Am J Cardiol; 1988 Dec; 62(19):20L-25L. PubMed ID: 3144163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias].
    Cassagneau B; Miquel JP; Puel JP; Mordant B; Kher A; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():113-9. PubMed ID: 3938253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety considerations and dosing guidelines for encainide in supraventricular arrhythmias.
    Soyka LF
    Am J Cardiol; 1988 Dec; 62(19):63L-68L. PubMed ID: 3144170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs.
    Feld GK; Chen PS; Nicod P; Fleck RP; Meyer D
    Am J Cardiol; 1990 Aug; 66(3):378-83. PubMed ID: 2114784
    [No Abstract]   [Full Text] [Related]  

  • 14. Atrial automatic ectopic tachycardia successfully treated with encainide in a 4-week-old infant after Senning procedure.
    Hays MD; Gillette PC
    Am Heart J; 1989 Feb; 117(2):489-92. PubMed ID: 2492740
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias.
    Orning OM
    Eur Heart J; 1984 Sep; 5 Suppl B():81-6. PubMed ID: 6437821
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and electrophysiologic effects of encainide for atrioventricular nodal reentrant tachycardia.
    Naccarelli GV; Jackman WM; Akhtar M; Rinkenberger RL; Friday KJ; Dougherty AH; Tchou P; Yeung-Lai-Wah JA
    Am J Cardiol; 1988 Dec; 62(19):31L-36L. PubMed ID: 3144165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interactions of quinidine and propranolol with mexiletine, encainide, flecainide and tocainide].
    Halawa B
    Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):222-4. PubMed ID: 2120685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias.
    Pritchett EL; Wilkinson WE
    Am J Cardiol; 1991 May; 67(11):976-80. PubMed ID: 1902055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flecainide and encainide.
    Furlanello F; Vergara G; Bettini R; Mosna G; Gramegna L; Disertori M
    Eur Heart J; 1987 Mar; 8 Suppl A():33-40. PubMed ID: 3107989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of ventricular tachycardia: wide, complex ignorance.
    Mason JW; Stinson EB; Winkle RA; Oyer PE
    Am Heart J; 1981 Dec; 102(6 Pt 1):1083-7. PubMed ID: 6797286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.